Skip to content

Database of Tissue Samples to Understand the Inflammatory Response After Cardiac Surgery

Non-individual Related Ongoing Collection of Blood Samples for the Compilation of a Unique Database of Tissue Samples to Understand the Inflammatory Response After Cardiac Surgery

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02488876
Enrollment
1000
Registered
2015-07-02
Start date
2009-04-30
Completion date
2099-12-31
Last updated
2017-10-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Diseases

Keywords

Cardiac surgery, Tissue sample database, Inflammatory responds

Brief summary

The aim of this study is to collect non-individual related blood samples for the compelling of a unique database of tissue samples to understand the inflammatory responds after cardiac surgery on an on-going basis. This includes especially protein analyses and genetic testing for certain neurotransmitters in the blood and tissues to understand disease markers related to heart disease. The study is designed as an openly recruiting biobank with the purpose to later serve multiple study purposes. Outcomes refer to protein analyses and genetic testing for neurotransmitters in the blood and tissues.

Interventions

None listed

Sponsors

RWTH Aachen University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Patients undergoing cardiac surgery

Exclusion criteria

* None.

Design outcomes

Primary

MeasureTime frame
Inflammatory CytokinesPerioperatively until 7 days after cardiac surgery

Countries

Germany

Contacts

Primary ContactAndreas Goetzenich, PD Dr. med.
agoetzenich@ukaachen.de+49 241 80 35556
Backup ContactChristian Stoppe, PD Dr. med.
cstoppe@ukaachen.de+49 241 80 36575

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 22, 2026